Search clinical trials for: Iptacopan (LNP023)
Total 37 results
-
Novartis PharmaceuticalsRecruitingC3 GlomerulopathySpain, France, Germany, Switzerland, United States, Japan, Turkey, China, United Kingdom, Italy, Argentina, Brazil, Greece, Israel, Netherlands
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsRecruitingLupus NephritisFrance, Spain, Israel, Turkey, United States, Germany, India, Hungary, Malaysia, Portugal, Brazil, China, Puerto Rico, Hong Kong, Mexico, Singapore
-
Novartis PharmaceuticalsRecruitingAge-Related Macular DegenerationChina, United States, Puerto Rico, United Kingdom
-
Novartis PharmaceuticalsRecruitingAtypical Hemolytic Uremic SyndromeJapan, Turkey
-
Novartis PharmaceuticalsActive, not recruitingImmune Thrombocytopenia (ITP) | Cold Agglutinin Disease (CAD)United States, Spain, Germany, Korea, Republic of, United Kingdom, Italy
-
Novartis PharmaceuticalsRecruitingAtypical Hemolytic Uremic SyndromeChina, Korea, Republic of, Austria, Taiwan, Greece, United States, Czechia, Japan, Brazil, United Kingdom, India, Slovenia, Slovakia
-
Novartis PharmaceuticalsRecruitingC3GSpain, France, Switzerland, Germany, Greece, Turkey, Canada, India, United States, Czechia, Japan, Argentina, Brazil, Italy, Israel, United Kingdom, China, Belgium, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingIgA NephropathyUnited States, Taiwan, Czechia, Germany, Hungary, India, Turkey, Belgium, Netherlands, Singapore, Australia, Canada, Italy, Korea, Republic of, Spain, Thailand, Denmark, Slovenia, United Kingdom, Argentina, Brazil, Israel, Japan, France, Swed... and more
-
Novartis PharmaceuticalsRecruitingPrimary IgA NephropathyJapan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)China, Germany, Singapore, Korea, Republic of, Italy, United Kingdom, Malaysia, France
-
Novartis PharmaceuticalsAvailableParoxysmal Nocturnal Hemoglobinuria (PNH) | C3 Glomerulopathy (C3G)
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH) With Signs of Active HemolysisItaly, Germany, France
-
Novartis PharmaceuticalsNot yet recruitingAtypical Hemolytic Uremic Syndrome
-
Novartis PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaUnited States, Korea, Republic of, Singapore, Germany, Taiwan, Italy, Turkey, France, Malaysia, Lithuania, Netherlands, United Kingdom, Japan, Czechia, Spain, China, Brazil
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal HemoglobinuriaTaiwan, Singapore, Korea, Republic of, Malaysia
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)Italy, Japan, Taiwan, Germany, France, United Kingdom, Spain, Korea, Republic of, Czechia, Brazil, Netherlands, United States
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria PNHLithuania, Japan, Czechia
-
Novartis PharmaceuticalsCompletedGlomerulonephritisSpain, Germany, France, United States, United Kingdom, Italy
-
Novartis PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaFrance, Spain, Italy, Turkey, Germany, United States, Korea, Republic of, United Kingdom
-
Novartis PharmaceuticalsCompletedIgA NephropathyColombia, Taiwan, Czechia, India, Turkey, Belgium, Netherlands, Singapore, Australia, Korea, Republic of, Thailand, Argentina, Germany, Israel, Japan, Sweden, United Kingdom, Brazil, China, Hong Kong, Norway, Finland, France, Denmark, M...
-
Novartis PharmaceuticalsRecruitingIC-MPGNFrance, Germany, Spain, Switzerland, Japan, United Kingdom, Israel, Brazil, Turkey, Italy, United States, Czechia, Poland
-
Novartis PharmaceuticalsActive, not recruitingStudy of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis (ONWARDS)OsteoarthritisTaiwan, Spain, United Kingdom, United States, Argentina, Australia, Denmark, India, China, Czechia, Canada, Japan, Poland, Mexico, Estonia
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompletedPrimary Osteoarthritis Patients Scheduled for Total Knee Replacement SurgeryUnited States
-
Novartis PharmaceuticalsCompletedOsteoarthritisUnited States, Denmark, Czechia
-
AngioLab, Inc.CompletedNonalcoholic SteatohepatitisKorea, Republic of
-
Novartis PharmaceuticalsCompletedStudy of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis ParticipantsOsteoarthritis | KneeJapan
-
Novartis PharmaceuticalsTerminatedGlomerulonephritis, MembranousCzechia, India, Taiwan, United Kingdom, Germany, Argentina, China, Netherlands, Spain
-
Hanmi Pharmaceutical Company LimitedTerminatedAbdominal Obesity Metabolic SyndromeKorea, Republic of
-
Medesis Pharma SARecruiting
-
Novartis PharmaceuticalsRecruitingKnee OsteoarthritisPoland, United States, Hungary, Russian Federation, Estonia, Germany, Czechia, Lithuania, Switzerland, China, Latvia
-
AngioLab, Inc.CompletedAge-Related Macular DegenerationKorea, Republic of
-
Handok Inc.Not yet recruiting
-
Aalborg UniversityUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Melanoma | Colitis | Lung Non-Small Cell Carcinoma | Malignant Genitourinary System NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Colitis | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung... and other conditionsUnited States